Characterization of antisense oligonucleotides comprising 2′-deoxy-2′-fluoro-β-D-arabinonucleic acid (FANA): Specificity, potency, and duration of activity

Annals of the New York Academy of Sciences

Volumn 1082, Issue , 2006, Pages 91-102

  Ferrari, Nicolay ^a   Bergeron, Denis ^a   Tedeschi, Anna Lisa ^a   Mangos, Maria M ^a   Paquet, Luc ^a   Renzi, Paolo M ^a,b   Damha, Masad J ^c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antisense oligonucleotide; FANA; Luciferase; siRNA

Indexed keywords

2' DEOXY 2' FLURO BETA DEXTRO ARABINONUCLEIC ACID; ANTISENSE OLIGODEOXYNUCLEOTIDE; NUCLEIC ACID; PHOSPHORODIESTER PHOSPHOROTHIOATE 2' O METHYL RNA DNA ANTISENSE OLIGONUCLEOTIDE; PHOSPHOROTHIOATE 2' DEOXY 2' FLUORO BETA DEXTRO ARABINONUCLEIC ACID ANTISENSE OLIGONUCLEOTIDE; PHOSPHOROTHIOATE 2' O METHYL RNA DNA ANTISENSE OLIGONUCLEOTIDE; PHOSPHOROTHIOATE DNA ANTISENSE OLIGONUCLEOTIDE; SMALL INTERFERING RNA;

CHIMERA; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DEGRADATION; DRUG EFFICACY; DRUG POTENCY; DRUG SPECIFICITY; DRUG STABILITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; SERUM;

EID: 33845644974     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1348.032     Document Type: Conference Paper

References (23)

1. ECKSTEIN, F. 2000. Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them? Antisense Nucleic Acid Drug Dev. 10: 117-121.
2. KURRECK, J. 2003. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270: 1628-1644.
3. Yoo, B.H. et al. 2004. 2′-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro. Nucleic Acids Res. 32: 2008-2016.
4. MCKAY, R.A. et al. 1999. Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. J. Biol. Chem. 274: 1715-1722.
5. WAHLESTEDT, C. et al. 2000. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl. Acad. Sci. USA 97: 5633-5638.
6. STERNBERGER, M. et al. 2002. GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation. Antisense Nucleic Acid Drug Dev. 12: 131-143.
7. WILDS, C.J. & M.J. DAMHA. 1999. Duplex recognition by oligonucleotides containing 2′-deoxy-2′-fluoro-D-arabinose and 2′-deoxy-2′-fluoro-D-ribose. Intermolecular 2′-OH-phosphate contacts versus sugar puckering in the stabilization of triple-helical complexes. Bioconjug. Chem. 10: 299-305.
8. WILDS, C.J. & M.J. DAMHA. 2000. 2′-Deoxy-2′-fluoro-beta- D-arabinonucleosides and oligonucleotides (2′F-ANA): synthesis andphysicochemical studies. Nucleic Acid Res. 28 3625-3635.
9. NORONHA, A.M. et al. 2000. Synthesis and biophysical properties of arabinonucleic acids (ANA): circular dichroic spectra, melting temperatures, and ribonuclease H susceptibility of ANA.RNA hybrid duplexes. Biochemistry 39: 7050-7062.
10. TREMPE, J.F. et al. 2001. NMR solution structure of an oligonucleotide hairpin with a 2′F-ANA/RNA stem: implications for RNase H specificity toward DNA/RNA hybrid duplexes. J. Am. Chem. Soc. 123: 4896-4903.
11. DAMHA, M.J. et al. 2001. Properties of arabinonucleic acids (ANA & 2′F-ANA): implications for the design of antisense therapeutics that invoke RNase H cleavage of RNA. Nucleosides Nucleotides Nucleic Acids 20: 429-440.
12. LOK, C.C. et al. 2002. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2′-deoxy-2′- fluoro-D-arabinose and 2′-deoxyribose nucleotides. Biochemistry 41: 3457-3467.
13. ACHENBACH, T.V., B. BRUNNER & K. HEERMEIER. 2003. Oligonucleotide-based knockdown technologies: antisense versus RNA interference. Chembiochem 4: 928-935.
14. SLEDZ, C.A. & B.R. WILLIAMS. 2004. RNA interference and double-stranded-RNA-activated pathways. Biochem. Soc. Trans. 32: 952-956.
15. SCHERER, L.J. & J.J. ROSSI. 2003. Approaches for sequence-specific knockdown of mRNA. Nat. Biotechnol. 21: 1457-1465.
16. ELBASHIR, S.M. et al. 2001. Duplexes of 21-nucleotide RNA s mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
17. CAPLEN, N.J. et al. 2001. Specific inhibition of gene expression by small double-stranded RNA s in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98 9742-9747.
18. GRUNWELLER, A. et al. 2003. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31: 3185-3193.
19. VICKERS, T.A. et al. 2003. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. J. Biol. Chem. 278: 7108-7118.
20. BRAASCH, D.A. et al. 2002. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Res. 30: 5160-5167.
21. JEPSEN, J.S. & J. WENGEL. 2004. LNA-antisense rivals siRNA for gene silencing. Curr. Opin. Drug Discov. Dev. 7: 188-194.
22. FILIPOWICZ, W. 2005. RNAi: the nuts and bolts of the RISC machine. Cell 122: 17-20.
23. Kalota, A. et al. 2006. 2′-Deoxy-2′-fluoro-β-D- arabinonucleic acid (2szligF-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing. Nucleic Acids Res. 34: 451-461.